Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 2Terminated 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 1Gastrointestinal 1

Conditions

Neoplasms 1Carcinoma, Hepatocellular 1Advanced Solid Tumors 1

Interventions

Cyclophosphamide 641Bevacizumab 552Paclitaxel 534Carboplatin 533Cisplatin 480pembrolizumab 456Gemcitabine 422Docetaxel 415Rituximab 386Radiotherapy 373Dexamethasone 351Doxorubicin 330Nivolumab 308Fluorouracil 286Capecitabine 260Etoposide 245Prednisone 244Oxaliplatin 242Erlotinib Hydrochloride 242Cytarabine 233Lenalidomide 232Trastuzumab 226Pemetrexed 220Vincristine 212fludarabine phosphate 208Leucovorin 208Cetuximab 208Filgrastim 204Bortezomib 193Methotrexate 183

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Has results × ascrinvacumab × Clear all
NCT01337050 2015-10-28

Asian Phase I Study Of PF-03446962

Pfizer

Phase 1 Completed
36 enrolled 24 charts
Gastrointestinal

Carcinoma, Hepatocellular, Neoplasms

NCT00557856 2015-10-19

A First In Patient, Study Of Investigational Drug PF-03446962 In Patients With Advanced Solid Tumors

Pfizer

Phase 1 Completed
70 enrolled 22 charts
Other solid neoplasm

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡